Should you buy Vocation Ltd today?

Turnarounds seldom turn, but is Vocation Ltd (ASX:VET) an exception to the rule?

a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The market has continued to cool on the prospects of embattled education provider Vocation Ltd (ASX: VET) after the stock surged as a result of the appointment of a new CEO.

Shares of the company surged nearly 160% from 8.1 cents to 21 cents in the three days following the announcement that outgoing CEO Mark Hutchinson would be replaced by Stewart Cummins. Cummins has a strong reputation for his ability to guide corporate turnarounds, which is very fitting for Vocation as it is still dealing with the aftermath of the loss of key funding from the Victorian government last year.

Unfortunately, it's been all downhill since then with the stock having retreated more than 40%. It's now trading at 12.5 cents, down 7.4% today alone.

While some investors will see this as an opportunity to buy a rundown stock in the hope of a major turnaround, it's worth remembering Warren Buffett's famous words: "Turnarounds seldom turn."

Sure, Vocation appears to be taking the necessary steps in getting its business back on track by selling 'non-core' businesses and reducing its debt. But it remains unclear just how the company will perform in its simplified structure.

Although investors could make a nice quick profit if everything goes according to plan, Vocation remains a highly risky investment prospect which should certainly be avoided by long-term investors – at least until they have been provided with greater clarity on the business' future.

Ryan Newman has no position in any stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »